PODD

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Insulet Corporation

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
CEO
Shacey Petrovic
Employees
1900
Headquarters

100 Nagog Park
Acton, Massachusetts 01720-3440
Phone: 19786007000
www.myomnipod.com

News

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
Jul 08, 2024 10:00am

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial results for the second quarter of 2024 on August 8, 2024 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space
Jun 29, 2024 15:35pm

The Health Care Select Sector SPDR Fund ETF (XLV) saw modest growth in Q2 2024.


Source:Seeking Alpha
Insulet''s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
Jun 21, 2024 22:40pm

https://www.investing.com/news/press-releases/insulets-securet2d-pivotal-trial-results-demonstrate-omnipod--5-improves-clinical-outcomes-and-quality-of-life-in-type-2-diabetes-93CH-3492680


Source:Investing.com
Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
Jun 21, 2024 22:30pm

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today shared positive results from its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) type 2 diabetes pivotal trial at the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, Florida. This landmark study evaluated the Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today
Jun 21, 2024 19:00pm

Insulet (NASDAQ: PODD ) has outperformed the market over the past 15 years by 12.24% on an annualized basis producing an average annual return of 24.76%. Currently, Insulet has a market capitalization of $14.24 billion. Buying $1000 In PODD: If an … Full story available on Benzinga.com


Source:Benzinga
Insulet (PODD) Faces Increasing Competition
Jun 21, 2024 14:59pm

ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The positive momentum in 2023 continued in the first quarter of 2024, the stocks surged on the expectation of a soft landing of the economy and a slowdown in rate […]


Source:Insider Monkey
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
Jun 20, 2024 10:16am

https://www.investing.com/news/press-releases/insulet-announces-full-commercial-launch-of-omnipod-5-with-expanded-sensor-integrations-in-the-united-kingdom-and-the-netherlands-93CH-3489674


Source:Investing.com
Insulet Corporation: Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
Jun 20, 2024 10:06am

Omnipod 5, the world''s first tubeless automated insulin delivery (AID) system integrated with Dexcom G6, is now available in France Full commercial launch of Omnipod 5 with Dexcom G7 integration h…


Source:Finanz Nachrichten
Insulet Corporation: Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
Jun 20, 2024 10:06am

Following a successful limited market release, the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) is now fully available with Dexcom G6 and Abbott FreeStyle Libre 2 Plus in these countrie…


Source:Finanz Nachrichten
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
Jun 20, 2024 10:00am

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today made several exciting announcements regarding the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), including its availability in France with Dexcom G6 compatibility, as well as two updates for the U.S. market — the commencement of the Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online